Literature DB >> 23729360

Super-radical surgery for anaplastic thyroid carcinoma: a large cohort study using the Anaplastic Thyroid Carcinoma Research Consortium of Japan database.

Iwao Sugitani1, Yasuhisa Hasegawa, Masashi Sugasawa, Masayuki Tori, Takuya Higashiyama, Masakazu Miyazaki, Hiroshi Hosoi, Yorihisa Orita, Hiroya Kitano.   

Abstract

BACKGROUND: The consequences of super-radical resection in patients with anaplastic thyroid carcinoma (ATC) have not been fully investigated.
METHODS: This retrospective study used the multicenter ATC Research Consortium of Japan database. Among 233 stage IVB patients, 23 underwent super-radical resection (group S). Outcomes for group S were compared to those for patients with restricted curative surgery (group R; n = 49), palliative surgery (group P; n = 72) or no surgery (group N; n = 80).
RESULTS: One-year cause-specific survival rate for group S was 33%. It was identical to group R (p = .94) and significantly better than groups N and P (p = .0065). Permanent tracheostomy was significantly more frequent in group S than in other groups, but only 5 patients died directly from local disease.
CONCLUSIONS: Radical resection offers significantly better outcomes than limited surgery. Super-radical procedures may be indicated in select patients to avoid mortality due to locally uncontrolled disease at the expense of tracheostomy.
Copyright © 2013 Wiley Periodicals, Inc., A Wiley Company.

Entities:  

Keywords:  anaplastic thyroid carcinoma; multicenter registry; prognostic factor; quality of life; super-radical surgery

Mesh:

Year:  2013        PMID: 23729360     DOI: 10.1002/hed.23295

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  5 in total

1.  Role of surgery to the primary tumor in metastatic anaplastic thyroid carcinoma: pooled analysis and SEER-based study.

Authors:  Dmytro Oliinyk; Teresa Augustin; Josefine Rauch; Viktoria Florentine Koehler; Claus Belka; Christine Spitzweg; Lukas Käsmann
Journal:  J Cancer Res Clin Oncol       Date:  2022-08-12       Impact factor: 4.322

Review 2.  Secondary tracheal tumors: a systematic review.

Authors:  Maria Lucia Madariaga; Henning A Gaissert
Journal:  Ann Cardiothorac Surg       Date:  2018-03

Review 3.  Clinical Trials in Management of Anaplastic Thyroid Carcinoma; Progressions and Set Backs: A Systematic Review.

Authors:  Behrouz Salehian; Simon Y Liem; Hoda Mojazi Amiri; Ellie Maghami
Journal:  Int J Endocrinol Metab       Date:  2019-01-13

4.  A Synergistic Anti-Cancer Effect of Troglitazone and Lovastatin in a Human Anaplastic Thyroid Cancer Cell Line and in a Mouse Xenograft Model.

Authors:  Wen-Bin Zhong; Yuan-Chin Tsai; Li-Han Chin; Jen-Ho Tseng; Li-Wen Tang; Steve Horng; Yu-Ching Fan; Sung-Po Hsu
Journal:  Int J Mol Sci       Date:  2018-06-22       Impact factor: 5.923

5.  Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma.

Authors:  Priyanka C Iyer; Ramona Dadu; Maria Gule-Monroe; Naifa L Busaidy; Renata Ferrarotto; Mouhammed Amir Habra; Mark Zafereo; Michelle D Williams; G Brandon Gunn; Horiana Grosu; Heath D Skinner; Erich M Sturgis; Neil Gross; Maria E Cabanillas
Journal:  J Immunother Cancer       Date:  2018-07-11       Impact factor: 13.751

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.